Form 8-K - Current report:
SEC Accession No. 0000885590-24-000004
Filing Date
2024-02-01
Accepted
2024-02-01 17:18:42
Documents
15
Period of Report
2024-01-29
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K bhc-20240129.htm   iXBRL 8-K 27761
2 EX-99.1 ex991-bodprjan2024.htm EX-99.1 9556
  Complete submission text file 0000885590-24-000004.txt   170822

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bhc-20240129.xsd EX-101.SCH 1922
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT bhc-20240129_lab.xml EX-101.LAB 25098
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bhc-20240129_pre.xml EX-101.PRE 13049
16 EXTRACTED XBRL INSTANCE DOCUMENT bhc-20240129_htm.xml XML 2889
Mailing Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8
Business Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8 514-744-6792
Bausch Health Companies Inc. (Filer) CIK: 0000885590 (see all company filings)

EIN.: 000000000 | State of Incorp.: NJ | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-14956 | Film No.: 24587942
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)